[1]
Fitriani, N.P. and Suyata 2024. The Role of Anti-PD 1 (Programmed Cell Death-1) (Pembrolizumab) in Hepatocellular Carcinoma: A Narrative Literature Review. Bioscientia Medicina : Journal of Biomedicine and Translational Research. 8, 4 (Feb. 2024), 4289-4296. DOI:https://doi.org/10.37275/bsm.v8i4.975.